Outcome and treatment in elderly patients with small cell lung cancer: A retrospective study

Geriatrics and Gerontology International

Volumn 9, Issue 2, 2009, Pages 172-182

  Li, Jian ^a   Chen, Ping ^a   Dai, Chun Hua ^a   Li, Xiao Qin ^a   Bao, Qian Lei ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

Chemotherapy; Elderly; Outcome; Radiotherapy; Small cell lung cancer

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ELDERLY CARE; ESOPHAGITIS; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; GERIATRIC PATIENT; HUMAN; LEUKOPENIA; LIVER TOXICITY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 66049115813     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2009.00525.x     Document Type: Article

References (30)

1. Vercelli M, Quaglia A, Casella C, Parodi S, Micheli A, Capocaccia R. Cancer in elderly: The population-based index in Europe (incidence, mortality, survival and prevalence). Ann Oncol 1998; 9 (Suppl. 3): 55-56.
2. Yancik R. Cancer burden in the aged. An epidemiologic and demographic overview. Cancer 1997; 80: 1273-1283.
3. Bunn PA, Lilenbann R. Chemotherapy for elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 2003; 95: 341-343.
4. Sekine I, Yamamoto N, Kunitoh H et al. Treatment of small cell lung cancer in the elderly based on a criteria literature review of clinical trials. Cancer Treat Rev 2004; 30: 359-368.
5. Gridelli C, De Vivo R, Monfardim S. Management of small cell lung cancer in the elderly. Crit Rev Oncol Hematol 2002; 41: 79-88.
6. Siu LL, Shepherd FA, Murray N, Feld R, Pater J, Zee B. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol 1996; 14: 821-828.
7. Quon H, Shepard FA, Payne DG et al. The influence of age on the delivery, tolerance and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 1999; 43: 39-45.
8. Yuen AR, Zou G, Turrisi AT et al. Similar outcome of elderly patients in intergroup trial 0096. Cisplatin, etoposide, and TR administered once or twice daily in limited stage small cell lung carcinoma. Cancer 2000; 89: 1953-1960.
9. Schhid SE, Stella PJ, Brook BJ et al. Results of combined-modality therapy for limited stage small cell lung carcinoma in the elderly. Cancer 2005; 103: 2349-2354.
10. Okamoto H, Watanabe K, Nishiwaki Y et al. Phase II study of area under the plasm-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small cell lung cancer. J Clin Oncol 1999; 17: 3540-3545.
11. Larive S, Bombaron P, Riou R et al. Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: A phase II trial. Lung Cancer 2002; 35: 1-7.
12. Fukuoka M, Furuse K, Saijo N et al. Randomized trial of cyclophosphamide, doxorubicin and vincristine versus cisplatin and etoposide versus alteration of these regimens in small-cell lung cancer. J Natl Cancer Inst 1991; 83: 855-861.
13. Roth BJ, Johnsen DH, Einhorn LH et al. Randomized study of cyclophosphamide, doxorubicin and vincristine versus etoposide and cisplatin versus alteration of these two regimens in extensive small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group. J Clin Onocl 1992; 10: 282-291.
14. Johnson D. Management of small cell lung cancer: Current state of the art. Chest 1999; 116 (Suppl.): S525-S530.
15. Sundstrom S, Bremnes RM, Kaasa S et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: Results from a randomized phase III trial with 5 year's follow-up. J Clin Oncol 2002; 20: 4665-4672.
16. Pignon JP, Arriagada R, Ihde DC et al. A meta-analysis of TR for small-cell lung cancer. N Engl J Med 1992; 327: 1618-1624.
17. Aupérin A, Arriagada R, Pignon JP et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission: Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999; 341: 476-484.
18. Sekine I, Fukuda H, Kuniton H, Saijo N. Cancer chemotherapy in the elderly. Jpn J Clin Oncol 1998; 28: 463-473.
19. Dajczman E, Fu LY, Small D et al. Treatment of small-cell lung carcinoma in the elderly. Cancer 1996; 77: 2032-2038.
20. Bremnes RM, Sundstrom S, Asaebo U et al. The value of prognostic factors in small cell lung cancer: Results from a randomized multicenter study with minimum 5 year follow-up. Lung Cancer 2003; 39: 303-313.
21. Yancik R, Gany PA, Varricchio CG et al. Perspective on comorbidity and cancer in older patients: Approaches to expend the knowledge base. J Clin Oncol 2001; 19: 1147-1151.
22. Maione P, Perrone F, Gallo C et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small cell lung cancer receiving chemotherapy: A prognostic analysis of the Multicenter Italian Lung cancer in the elderly patients. J Clin Oncol 2005; 23: 6865-6872.
23. Perry MC, Herndon JE 3rd, Eaton WL et al. Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: An update of cancer and Leukemia Group B Study 8083. J Clin Oncol 1998; 16: 2466-2467.
24. Lebeau B, Chastang CI, Urban T et al. A randomized clinical trial comparing concurrent and alternated thoracic irradiation in limited small cell cancer (SCLC) [abstract 1148]. Proc Am Soc Clin Oncol 1996; 15: 383.
25. Takada M, Fukuoka M, Kawahara M et al. Phase III study of concurrent versus sequential TR in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002; 20: 3054-3061.
26. Radford JA, Ryder WD, Dodwell D et al. Predicting septic complication of chemotherapy. An analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis. Eur J Cancer 1992; 29A: 81-86.
27. Crawford J, Ozer H, Stoller R et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991; 325: 164-170.
28. Sculier JP, Joss RA, Schefer H et al. Should maintenance chemotherapy be used to treat small cell lung cancer? Eur J Cancer 1998; 34: 1148-1155.
29. Murray N, Grafton C, Shan A et al. Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer. J Clin Oncol 1998; 16: 3323-3328.
30. Jeremic B, Shibamoto Y, Acimovic L et al. Carboplatin etoposide, and accelerated hyperfractionated RT for elderly patients with limited small cell lung carcinoma: A phase II study. Cancer 1998; 82: 836-841.